期刊文献+

Synthesis and Crystal Structure of 3-(Trichloroacetyl) Indole

Synthesis and Crystal Structure of 3-(Trichloroacetyl) Indole
下载PDF
导出
摘要 Trichloroacetyl) indole has been synthesized by the reaction of indole with trichloroacetyl chloride in 73% yield, and its crystal structure was determined by X-ray diffraction method. The crystal is of orthorhombic, space group Pnma with a = 20.781(7), b = 6.857(2), c = 7.431(3) ?, V = 1058.8(6) ?3, Z = 4, Mr = 262.51, Dc = 1.647 g/cm3, λ = 0.71073 ?, μ(MoKα) = 0.833 mm? and F(000) = 528. The structure was refined to R = 0.0286 and wR = 0.0749 for 1073 1 observed reflections with I > 2σ(I). It exhibits a characteristic plane structure consisting of all atoms except Cl(2) and Cl(2)A. Two kinds of intermolecular hydrogen bonds are formed: N(1)– H(8A)…O(1) and N(1)–H(8A)…Cl(1). There also exist three kinds of π-π stacking in the crystal. Trichloroacetyl) indole has been synthesized by the reaction of indole with trichloroacetyl chloride in 73% yield, and its crystal structure was determined by X-ray diffraction method. The crystal is of orthorhombic, space group Pnma with a = 20.781(7), b = 6.857(2), c = 7.431(3) ?, V = 1058.8(6) ?3, Z = 4, Mr = 262.51, Dc = 1.647 g/cm3, λ = 0.71073 ?, μ(MoKα) = 0.833 mm? and F(000) = 528. The structure was refined to R = 0.0286 and wR = 0.0749 for 1073 1 observed reflections with I > 2σ(I). It exhibits a characteristic plane structure consisting of all atoms except Cl(2) and Cl(2)A. Two kinds of intermolecular hydrogen bonds are formed: N(1)– H(8A)…O(1) and N(1)–H(8A)…Cl(1). There also exist three kinds of π-π stacking in the crystal.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 北大核心 2005年第3期299-302,共4页 结构化学(英文)
基金 The project was supported by the National 863 Program of China (No. 2001AA628100) and Natural Science Foundation of Guangdong Province (No. 31920)
关键词 trichloroacetyl)indole INDOLE SYNTHESIS crystal structure trichloroacetyl)indole, indole, synthesis, crystal structure
  • 相关文献

参考文献7

  • 1Shi, L.; Wang, X. P.; Cai, T. X. Chin. J Org. Chem. 2811, 21,200-204.
  • 2Jiang, B.; Xiong, W. N.; Yang, C. G. Bioorganic & Medicinal Chemistry 2002, 10, 2775-2778.
  • 3Arimondo, R B., Baldeyrou, B.; Laine, W.; Bal, C.; Alphonse, E C.: Routier, S.; Coudert, G.,Merour L Y., Colson, P.: Houssier, C.; Bailly, C. Chemico-Biological Interactions 2001, 138, 59-75.
  • 4Li, Q.; Woods, K. W.; Ciaibome, A.; Gwaltney, S. L.; Barr, K. J., Liu, G.; Gehrke, L.; Credo, R. B.; Hui, Y. H.; Lee, J.;Warner, R. B., Kovar P.; Nukkala, M. A. Bioorganic & Medicinal Chemistry Letters 2002, 12,465-469.
  • 5Voldoire, A.; Sancelme, M.; Prudhomme, M.; Colson, R; Houssier, C.; Bailly, C.; Leonce, S.; Lambel, S.Bioorganic & Medicinal Chemistry 2001, 9, 357-365.
  • 6Bruker AXS, SHELXTL, Version 5.1, Bruker AXS, Madison, WI, USA 1998.
  • 7Sheldrick, G. M. SHEI.,X 97, Program for X-ray Crystal Structure Solution and Refinement, G6ttingen University, Germany 1997.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部